Global Procalcitonin Market Analysis and Forecast 2024-2030

Global Procalcitonin Market Analysis and Forecast 2024-2030


Summary

Procalcitonin (PCT), CAS 56645-65-9, is a 116 amino acid residue protein with a molecular weight of approximately 13kDa. Procalcitonin is a peptide hormone mainly produced by the C cells of the thyroid and certain endocrine cells of the lung. Under normal expression conditions, procalcitonin is immediately cleaved into three specific fragments, an N terminal residue, calcitonin and katacalcin. It can be expressed in E. coli

According to APO Research, The global Procalcitonin market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Procalcitonin is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Asia-Pacific market for Procalcitonin is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Procalcitonin is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Europe market for Procalcitonin is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The major global manufacturers of Procalcitonin include Thermo Fisher, Roche Diagnostics, bioMerieux, HyTest, BBI Solutions, ProSpec, Wondfo, Ningbo Medicalsystem Biotechnology and Wuhan Easy Diagnosis Biomedicine, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Procalcitonin, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Procalcitonin, also provides the sales of main regions and countries. Of the upcoming market potential for Procalcitonin, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Procalcitonin sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Procalcitonin market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Procalcitonin sales, projected growth trends, production technology, application and end-user industry.

Procalcitonin segment by Company

Thermo Fisher
Roche Diagnostics
bioMerieux
HyTest
BBI Solutions
ProSpec
Wondfo
Ningbo Medicalsystem Biotechnology
Wuhan Easy Diagnosis Biomedicine
Snibe
Vazyme Biotech
Getein Biotech
Hotgen Biotech
Lumigenex
Nanjing Norman Biological Technology
Kitgen
Beijing KeyGen
Beijing Apis
Procalcitonin segment by Type

Procalcitonin Antigen
Procalcitonin Antibody
Procalcitonin segment by Application

Medical Industry
Scientific Research
Veterinarian
Procalcitonin segment by Region

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Procalcitonin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Procalcitonin and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Procalcitonin.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Procalcitonin in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Procalcitonin manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Procalcitonin sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America (US & Canada) by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: Middle East, Africa, and Latin America type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.


1 Market Overview
1.1 Product Definition
1.2 Procalcitonin Market by Type
1.2.1 Global Procalcitonin Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 Procalcitonin Antigen
1.2.3 Procalcitonin Antibody
1.3 Procalcitonin Market by Application
1.3.1 Global Procalcitonin Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 Medical Industry
1.3.3 Scientific Research
1.3.4 Veterinarian
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Procalcitonin Market Dynamics
2.1 Procalcitonin Industry Trends
2.2 Procalcitonin Industry Drivers
2.3 Procalcitonin Industry Opportunities and Challenges
2.4 Procalcitonin Industry Restraints
3 Global Market Growth Prospects
3.1 Global Procalcitonin Revenue Estimates and Forecasts (2019-2030)
3.2 Global Procalcitonin Revenue by Region
3.2.1 Global Procalcitonin Revenue by Region: 2019 VS 2023 VS 2030
3.2.2 Global Procalcitonin Revenue by Region (2019-2024)
3.2.3 Global Procalcitonin Revenue by Region (2025-2030)
3.2.4 Global Procalcitonin Revenue Market Share by Region (2019-2030)
3.3 Global Procalcitonin Sales Estimates and Forecasts 2019-2030
3.4 Global Procalcitonin Sales by Region
3.4.1 Global Procalcitonin Sales by Region: 2019 VS 2023 VS 2030
3.4.2 Global Procalcitonin Sales by Region (2019-2024)
3.4.3 Global Procalcitonin Sales by Region (2025-2030)
3.4.4 Global Procalcitonin Sales Market Share by Region (2019-2030)
3.5 US & Canada
3.6 Europe
3.7 China
3.8 Asia (Excluding China)
3.9 Middle East, Africa and Latin America
4 Market Competitive Landscape by Manufacturers
4.1 Global Procalcitonin Revenue by Manufacturers
4.1.1 Global Procalcitonin Revenue by Manufacturers (2019-2024)
4.1.2 Global Procalcitonin Revenue Market Share by Manufacturers (2019-2024)
4.1.3 Global Procalcitonin Manufacturers Revenue Share Top 10 and Top 5 in 2023
4.2 Global Procalcitonin Sales by Manufacturers
4.2.1 Global Procalcitonin Sales by Manufacturers (2019-2024)
4.2.2 Global Procalcitonin Sales Market Share by Manufacturers (2019-2024)
4.2.3 Global Procalcitonin Manufacturers Sales Share Top 10 and Top 5 in 2023
4.3 Global Procalcitonin Sales Price by Manufacturers (2019-2024)
4.4 Global Procalcitonin Key Manufacturers Ranking, 2022 VS 2023 VS 2024
4.5 Global Procalcitonin Key Manufacturers Manufacturing Sites & Headquarters
4.6 Global Procalcitonin Manufacturers, Product Type & Application
4.7 Global Procalcitonin Manufacturers Commercialization Time
4.8 Market Competitive Analysis
4.8.1 Global Procalcitonin Market CR5 and HHI
4.8.2 2023 Procalcitonin Tier 1, Tier 2, and Tier 3
5 Procalcitonin Market by Type
5.1 Global Procalcitonin Revenue by Type
5.1.1 Global Procalcitonin Revenue by Type (2019 VS 2023 VS 2030)
5.1.2 Global Procalcitonin Revenue by Type (2019-2030) & (US$ Million)
5.1.3 Global Procalcitonin Revenue Market Share by Type (2019-2030)
5.2 Global Procalcitonin Sales by Type
5.2.1 Global Procalcitonin Sales by Type (2019 VS 2023 VS 2030)
5.2.2 Global Procalcitonin Sales by Type (2019-2030) & (mg)
5.2.3 Global Procalcitonin Sales Market Share by Type (2019-2030)
5.3 Global Procalcitonin Price by Type
6 Procalcitonin Market by Application
6.1 Global Procalcitonin Revenue by Application
6.1.1 Global Procalcitonin Revenue by Application (2019 VS 2023 VS 2030)
6.1.2 Global Procalcitonin Revenue by Application (2019-2030) & (US$ Million)
6.1.3 Global Procalcitonin Revenue Market Share by Application (2019-2030)
6.2 Global Procalcitonin Sales by Application
6.2.1 Global Procalcitonin Sales by Application (2019 VS 2023 VS 2030)
6.2.2 Global Procalcitonin Sales by Application (2019-2030) & (mg)
6.2.3 Global Procalcitonin Sales Market Share by Application (2019-2030)
6.3 Global Procalcitonin Price by Application
7 Company Profiles
7.1 Thermo Fisher
7.1.1 Thermo Fisher Comapny Information
7.1.2 Thermo Fisher Business Overview
7.1.3 Thermo Fisher Procalcitonin Sales, Revenue, Price and Gross Margin (2019-2024)
7.1.4 Thermo Fisher Procalcitonin Product Portfolio
7.1.5 Thermo Fisher Recent Developments
7.2 Roche Diagnostics
7.2.1 Roche Diagnostics Comapny Information
7.2.2 Roche Diagnostics Business Overview
7.2.3 Roche Diagnostics Procalcitonin Sales, Revenue, Price and Gross Margin (2019-2024)
7.2.4 Roche Diagnostics Procalcitonin Product Portfolio
7.2.5 Roche Diagnostics Recent Developments
7.3 bioMerieux
7.3.1 bioMerieux Comapny Information
7.3.2 bioMerieux Business Overview
7.3.3 bioMerieux Procalcitonin Sales, Revenue, Price and Gross Margin (2019-2024)
7.3.4 bioMerieux Procalcitonin Product Portfolio
7.3.5 bioMerieux Recent Developments
7.4 HyTest
7.4.1 HyTest Comapny Information
7.4.2 HyTest Business Overview
7.4.3 HyTest Procalcitonin Sales, Revenue, Price and Gross Margin (2019-2024)
7.4.4 HyTest Procalcitonin Product Portfolio
7.4.5 HyTest Recent Developments
7.5 BBI Solutions
7.5.1 BBI Solutions Comapny Information
7.5.2 BBI Solutions Business Overview
7.5.3 BBI Solutions Procalcitonin Sales, Revenue, Price and Gross Margin (2019-2024)
7.5.4 BBI Solutions Procalcitonin Product Portfolio
7.5.5 BBI Solutions Recent Developments
7.6 ProSpec
7.6.1 ProSpec Comapny Information
7.6.2 ProSpec Business Overview
7.6.3 ProSpec Procalcitonin Sales, Revenue, Price and Gross Margin (2019-2024)
7.6.4 ProSpec Procalcitonin Product Portfolio
7.6.5 ProSpec Recent Developments
7.7 Wondfo
7.7.1 Wondfo Comapny Information
7.7.2 Wondfo Business Overview
7.7.3 Wondfo Procalcitonin Sales, Revenue, Price and Gross Margin (2019-2024)
7.7.4 Wondfo Procalcitonin Product Portfolio
7.7.5 Wondfo Recent Developments
7.8 Ningbo Medicalsystem Biotechnology
7.8.1 Ningbo Medicalsystem Biotechnology Comapny Information
7.8.2 Ningbo Medicalsystem Biotechnology Business Overview
7.8.3 Ningbo Medicalsystem Biotechnology Procalcitonin Sales, Revenue, Price and Gross Margin (2019-2024)
7.8.4 Ningbo Medicalsystem Biotechnology Procalcitonin Product Portfolio
7.8.5 Ningbo Medicalsystem Biotechnology Recent Developments
7.9 Wuhan Easy Diagnosis Biomedicine
7.9.1 Wuhan Easy Diagnosis Biomedicine Comapny Information
7.9.2 Wuhan Easy Diagnosis Biomedicine Business Overview
7.9.3 Wuhan Easy Diagnosis Biomedicine Procalcitonin Sales, Revenue, Price and Gross Margin (2019-2024)
7.9.4 Wuhan Easy Diagnosis Biomedicine Procalcitonin Product Portfolio
7.9.5 Wuhan Easy Diagnosis Biomedicine Recent Developments
7.10 Snibe
7.10.1 Snibe Comapny Information
7.10.2 Snibe Business Overview
7.10.3 Snibe Procalcitonin Sales, Revenue, Price and Gross Margin (2019-2024)
7.10.4 Snibe Procalcitonin Product Portfolio
7.10.5 Snibe Recent Developments
7.11 Vazyme Biotech
7.11.1 Vazyme Biotech Comapny Information
7.11.2 Vazyme Biotech Business Overview
7.11.3 Vazyme Biotech Procalcitonin Sales, Revenue, Price and Gross Margin (2019-2024)
7.11.4 Vazyme Biotech Procalcitonin Product Portfolio
7.11.5 Vazyme Biotech Recent Developments
7.12 Getein Biotech
7.12.1 Getein Biotech Comapny Information
7.12.2 Getein Biotech Business Overview
7.12.3 Getein Biotech Procalcitonin Sales, Revenue, Price and Gross Margin (2019-2024)
7.12.4 Getein Biotech Procalcitonin Product Portfolio
7.12.5 Getein Biotech Recent Developments
7.13 Hotgen Biotech
7.13.1 Hotgen Biotech Comapny Information
7.13.2 Hotgen Biotech Business Overview
7.13.3 Hotgen Biotech Procalcitonin Sales, Revenue, Price and Gross Margin (2019-2024)
7.13.4 Hotgen Biotech Procalcitonin Product Portfolio
7.13.5 Hotgen Biotech Recent Developments
7.14 Lumigenex
7.14.1 Lumigenex Comapny Information
7.14.2 Lumigenex Business Overview
7.14.3 Lumigenex Procalcitonin Sales, Revenue, Price and Gross Margin (2019-2024)
7.14.4 Lumigenex Procalcitonin Product Portfolio
7.14.5 Lumigenex Recent Developments
7.15 Nanjing Norman Biological Technology
7.15.1 Nanjing Norman Biological Technology Comapny Information
7.15.2 Nanjing Norman Biological Technology Business Overview
7.15.3 Nanjing Norman Biological Technology Procalcitonin Sales, Revenue, Price and Gross Margin (2019-2024)
7.15.4 Nanjing Norman Biological Technology Procalcitonin Product Portfolio
7.15.5 Nanjing Norman Biological Technology Recent Developments
7.16 Kitgen
7.16.1 Kitgen Comapny Information
7.16.2 Kitgen Business Overview
7.16.3 Kitgen Procalcitonin Sales, Revenue, Price and Gross Margin (2019-2024)
7.16.4 Kitgen Procalcitonin Product Portfolio
7.16.5 Kitgen Recent Developments
7.17 Beijing KeyGen
7.17.1 Beijing KeyGen Comapny Information
7.17.2 Beijing KeyGen Business Overview
7.17.3 Beijing KeyGen Procalcitonin Sales, Revenue, Price and Gross Margin (2019-2024)
7.17.4 Beijing KeyGen Procalcitonin Product Portfolio
7.17.5 Beijing KeyGen Recent Developments
7.18 Beijing Apis
7.18.1 Beijing Apis Comapny Information
7.18.2 Beijing Apis Business Overview
7.18.3 Beijing Apis Procalcitonin Sales, Revenue, Price and Gross Margin (2019-2024)
7.18.4 Beijing Apis Procalcitonin Product Portfolio
7.18.5 Beijing Apis Recent Developments
8 North America
8.1 North America Procalcitonin Market Size by Type
8.1.1 North America Procalcitonin Revenue by Type (2019-2030)
8.1.2 North America Procalcitonin Sales by Type (2019-2030)
8.1.3 North America Procalcitonin Price by Type (2019-2030)
8.2 North America Procalcitonin Market Size by Application
8.2.1 North America Procalcitonin Revenue by Application (2019-2030)
8.2.2 North America Procalcitonin Sales by Application (2019-2030)
8.2.3 North America Procalcitonin Price by Application (2019-2030)
8.3 North America Procalcitonin Market Size by Country
8.3.1 North America Procalcitonin Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
8.3.2 North America Procalcitonin Sales by Country (2019 VS 2023 VS 2030)
8.3.3 North America Procalcitonin Price by Country (2019-2030)
8.3.4 U.S.
8.3.5 Canada
9 Europe
9.1 Europe Procalcitonin Market Size by Type
9.1.1 Europe Procalcitonin Revenue by Type (2019-2030)
9.1.2 Europe Procalcitonin Sales by Type (2019-2030)
9.1.3 Europe Procalcitonin Price by Type (2019-2030)
9.2 Europe Procalcitonin Market Size by Application
9.2.1 Europe Procalcitonin Revenue by Application (2019-2030)
9.2.2 Europe Procalcitonin Sales by Application (2019-2030)
9.2.3 Europe Procalcitonin Price by Application (2019-2030)
9.3 Europe Procalcitonin Market Size by Country
9.3.1 Europe Procalcitonin Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
9.3.2 Europe Procalcitonin Sales by Country (2019 VS 2023 VS 2030)
9.3.3 Europe Procalcitonin Price by Country (2019-2030)
9.3.4 Germany
9.3.5 France
9.3.6 U.K.
9.3.7 Italy
9.3.8 Russia
10 China
10.1 China Procalcitonin Market Size by Type
10.1.1 China Procalcitonin Revenue by Type (2019-2030)
10.1.2 China Procalcitonin Sales by Type (2019-2030)
10.1.3 China Procalcitonin Price by Type (2019-2030)
10.2 China Procalcitonin Market Size by Application
10.2.1 China Procalcitonin Revenue by Application (2019-2030)
10.2.2 China Procalcitonin Sales by Application (2019-2030)
10.2.3 China Procalcitonin Price by Application (2019-2030)
11 Asia (Excluding China)
11.1 Asia Procalcitonin Market Size by Type
11.1.1 Asia Procalcitonin Revenue by Type (2019-2030)
11.1.2 Asia Procalcitonin Sales by Type (2019-2030)
11.1.3 Asia Procalcitonin Price by Type (2019-2030)
11.2 Asia Procalcitonin Market Size by Application
11.2.1 Asia Procalcitonin Revenue by Application (2019-2030)
11.2.2 Asia Procalcitonin Sales by Application (2019-2030)
11.2.3 Asia Procalcitonin Price by Application (2019-2030)
11.3 Asia Procalcitonin Market Size by Country
11.3.1 Asia Procalcitonin Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
11.3.2 Asia Procalcitonin Sales by Country (2019 VS 2023 VS 2030)
11.3.3 Asia Procalcitonin Price by Country (2019-2030)
11.3.4 Japan
11.3.5 South Korea
11.3.6 India
11.3.7 Australia
11.3.8 China Taiwan
11.3.9 Southeast Asia
12 Middle East, Africa and Latin America
12.1 MEALA Procalcitonin Market Size by Type
12.1.1 MEALA Procalcitonin Revenue by Type (2019-2030)
12.1.2 MEALA Procalcitonin Sales by Type (2019-2030)
12.1.3 MEALA Procalcitonin Price by Type (2019-2030)
12.2 MEALA Procalcitonin Market Size by Application
12.2.1 MEALA Procalcitonin Revenue by Application (2019-2030)
12.2.2 MEALA Procalcitonin Sales by Application (2019-2030)
12.2.3 MEALA Procalcitonin Price by Application (2019-2030)
12.3 MEALA Procalcitonin Market Size by Country
12.3.1 MEALA Procalcitonin Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
12.3.2 MEALA Procalcitonin Sales by Country (2019 VS 2023 VS 2030)
12.3.3 MEALA Procalcitonin Price by Country (2019-2030)
12.3.4 Mexico
12.3.5 Brazil
12.3.6 Israel
12.3.7 Argentina
12.3.8 Colombia
12.3.9 Turkey
12.3.10 Saudi Arabia
12.3.11 UAE
13 Value Chain and Sales Channels Analysis
13.1 Procalcitonin Value Chain Analysis
13.1.1 Procalcitonin Key Raw Materials
13.1.2 Raw Materials Key Suppliers
13.1.3 Manufacturing Cost Structure
13.1.4 Procalcitonin Production Mode & Process
13.2 Procalcitonin Sales Channels Analysis
13.2.1 Direct Comparison with Distribution Share
13.2.2 Procalcitonin Distributors
13.2.3 Procalcitonin Customers
14 Concluding Insights
15 Appendix
15.1 Reasons for Doing This Study
15.2 Research Methodology
15.3 Research Process
15.4 Authors List of This Report
15.5 Data Source
15.5.1 Secondary Sources
15.5.2 Primary Sources
15.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings